ScreenerHero

XVIVO Xvivo Perfusion AB (publ)

STO · SE · Healthcare · Medical Devices · xvivogroup.com
214.40SEK+0.37%Mkt Cap: 645.99M $P/E: 76.03

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc.
$32.79BUSDP/E 34.5
GEHC
GE HealthCare Technologies Inc.
$29.90BUSDP/E 15.1
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
TXG
10x Genomics, Inc.
$12.73BUSD
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
BRKR
Bruker Corporation
$9.73BUSD

Key Statistics

Company
Market Cap645.99M USD
Enterprise Value626.04M USD
Revenue (TTM)85.63M USD
Gross Profit57.34M USD
Net Income (TTM)2.41M USD
Revenue/Share28.42 SEK
Last Price214.40 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees197
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718
Valuation
P/E (Trailing)76.03
P/E (Forward)36.14
PEG—
EV/EBITDA41.36
EV/Revenue7.31
P/S7.52
P/B3.06
EPS (TTM)2.82
EPS (Forward)5.91
52W Range
160.0035% of range314.80
52W High314.80 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
Oper. Margin10.46%
EBITDA Margin17.68%
Profit Margin3.10%
ROE1.19%
ROA1.06%
Growth
Revenue Growth34.00%
Earnings Growth935.10%
Cash Flow & Leverage
Operating CF9.67M USD
CapEx (TTM)24.19M USD
FCF Margin-3.24%
FCF Yield-0.43%
Net Debt-17.54M USD
Net Debt/EBITDA-1.16
Balance Sheet
Debt/Equity0.06
Current Ratio3.86
Quick Ratio2.65
Book Value/Sh69.85 SEK
Cash/Share9.68 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)335.60 SEK
Upside (mean)+56.5%
Target Range300.00 SEK – 385.00 SEK
300.00+56.5% to mean385.00
# Analysts5
Ownership
Shares Out.31.50M
Float25.13M
Insiders8.33%
Institutions59.80%
Technical
SMA 50261.93 (-18.1%)
SMA 200242.78 (-11.7%)
Beta1.46
S&P 52W Chg14.58%
Avg Vol (30d)67.12K
Avg Vol (10d)109.52K
Technical Indicators
RSI (14)24.8
MACD-12.2860
MACD Signal-9.7323
MACD Hist.-2.5538
BB Upper270.21 SEK
BB Middle240.65 SEK
BB Lower211.09 SEK
BB Width24.57%
ATR (14)9.154 SEK
Vol Ratio (20d)0.75x